Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant to lidocaine + ropivacaine for ultrasound-guided sciatic nerve block
ChiCTR-TRC-14004592Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, lidocaine and ropivacaine in Varicose Veins (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Sensory onset time of lateral sural cutaneous nerve, Sensory onset time of sural nerve and 12 more. Started Jul 2014; status: completed.
02
Drugs
dexmedetomidinelidocaineropivacaine
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on ChiCTR-TRC-14004592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004592.